Texas Oncology-Arlington South — Arlington, Texas

Texas Oncology-Arlington South is a clinical research site located in Arlington, Texas, United States 76014.

Crixeo Health Trust Score: 77/100 (FAIR). This profile has not yet been claimed by the site owner.

Texas Oncology-Arlington South has participated in 13 clinical trials with 3 currently active.

Therapeutic areas: Lymphoma, Non-Hodgkin, Endometrial Clear Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma.

Sponsors: Celgene, Gynecologic Oncology Group, Eli Lilly and Company.

Sponsor Feasibility Report

Trust Score: 77/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Texas Oncology-Arlington South?

Texas Oncology-Arlington South has a Crixeo Trust Score of 77/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Texas Oncology-Arlington South conducted?

Texas Oncology-Arlington South has 13 clinical trials on record, with 3 currently active. Their work covers Lymphoma, Non-Hodgkin, Endometrial Clear Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma.

Is Texas Oncology-Arlington South accredited by Crixeo Health?

Yes — Texas Oncology-Arlington South holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Texas Oncology-Arlington South?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.